Explore Clinical Trials

Clinical trials offer early access to cutting-edge treatments that can lead to progress in research, improved treatment options, and better outcomes. Through clinical trials, researchers can better understand how to diagnose, treat, and prevent diseases or conditions, which brings us one step closer to a world without autoimmune disease.

ARISE Study for CIDP

Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Learn more


SunStone: A Study of Obexelimab in Patients with Systemic Lupus Erythematosus

A phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Obexelimab in patients with systemic lupus erythematosus.

Learn more


TAK-279 for Crohn’s Disease

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn’s Disease.

Learn more


TAK-279 for Ulcerative Colitis

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis.

Learn more

Current Clinical Trials

Browse current studies with filters that allow you to search by condition, treatment, location, and more.

ClinicalTrials.gov
CenterWatch
ResearchMatch